Kenneth C Frazier

Mr. Frazier will oversee more than 30,000 employees and have direct responsibility for Merck's marketing and sales organizations worldwide including the global pharmaceutical and vaccine franchises.  Under Mr. Frazier's leadership, the Global Human Health organization will prepare, launch and market new products to maximize their long-term potential; optimize the performance of existing Merck products; and ensure a high-performing marketing and sales operation worldwide.  He also will work with his successor, Bruce N. Kuhlik, on the Company's VIOXX-related issues.  Mr. Frazier will continue to report directly to Richard T. Clark, Merck's chairman, president and chief executive officer, and serve on the Company's executive committee. Mr. Frazier has served as Merck's general counsel since 1999, first as senior vice president, and then promoted to executive vice president in 2006.  Prior to that role, he held positions of increasing responsibility for Merck & Co., Inc. as vice president and deputy general counsel (1999), assistant general counsel for corporate staff (1997), and vice president of public affairs (1994).  Mr. Frazier joined Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group.  Before joining Merck, he was a partner with the Philadelphia firm of Drinker Biddle & Reath. Mr. Frazier, 52, earned a B.A. in Political Science from Pennsylvania State University in 1975 and a J.D. from Harvard Law School in 1978. Bruce N. Kuhlik, who is being promoted to senior vice president, will succeed Mr. Frazier as general counsel with responsibility for Merck's legal and public affairs functions.  He will report directly to Mr. Clark and serve as a member of the executive committee which evaluates and makes strategic decisions for the Company.